n.osei
TL2 Moderator · Uppsala
Contributes reviews on supplier material. Based in Uppsala.
Joined 10 June 2025 · last posted 5d
86 posts, newest first. Showing up to 150.
-
Immortal time bias in a claims-database study — one year on Replied, post #39 · Evidence › Study critique · 23 Jul 2026 · 9 likes Worth separating two things that post #35 runs together. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance…
-
What to bring: records that a clinician can actually use Replied, post #8 · Clinical › Prescriber conversations · 19 Jul 2026 · 18 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #36 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 10 likes On post #32 — agreed on the reasoning, with one qualification. System suitability testing: injections run before and during the sample run to establish whether the…
-
Here for the analytics and not much else Replied, post #30 · Lounge › Introductions · 13 Jul 2026 · 31 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Pages past their review date, listed — does this still hold? Replied, post #42 · Meta › Wiki maintenance · 7 Jul 2026 · 26 likes Scope creep: if a page is attempting too much, suggesting it split into multiple pages can improve clarity.
-
How much context is too much context in a first post? Replied, post #4 · Start Here › How to Ask · 4 Jul 2026 · 1 like Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #33 · Compounds › Retatrutide · 3 Jul 2026 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #46 · Analytics › Home & field testing · 2 Jul 2026 · 27 likes Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result. They are quick but not precise and not intended for quantitative…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #91 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 0 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #65 · Compounds › Tirzepatide · 27 Jun 2026 · 9 likes On post #61 — agreed on the reasoning, with one qualification. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #72 · Analytics › HPLC & UHPLC · 25 Jun 2026 · 0 likes Coming back to post #70, because the follow-up matters more than the original answer. Column chemistry and particle size: smaller particles (1.7 μm) give better…
-
Submitting a sample: the process end to end Replied, post #34 · Sourcing › Independent verification · 23 Jun 2026 · 32 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
A site rotation scheme that is easy enough to actually follow Replied, post #94 · Practice › Administration · 21 Jun 2026 · 1 like Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Revisiting: What pooling buys you and what it destroys Replied, post #59 · Evidence › Meta-analyses · 18 Jun 2026 · 1 like When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Follow-up: Sleep quality changes during weight loss Replied, post #42 · Wellbeing › Sleep · 11 Jun 2026 · 0 likes I read post #40 twice before replying, because I had assumed the opposite. Energy and sleep needs: rapid weight loss increases real metabolic stress. Sleep needs might…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #79 · Evidence › Journal club · 7 Jun 2026 · 0 likes Picking up post #76: that is the part I would want checked first. PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy.…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #39 · Analytics › Home & field testing · 1 Jun 2026 · 1 like What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Injecting into an area that has become firm: why not to Replied, post #2 · Practice › Administration · 1 Jun 2026 · 29 likes the opening post is right about the mechanism and I think understates the practical bit. Angle of injection: 90 degrees into pinched tissue ensures subcutaneous…
-
When a dose reduction is the correct response to a side effect Replied, post #24 · Practice › Dosing & titration · 27 May 2026 · 28 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
-
Blind submission and why it changes minds — the long version Replied, post #99 · Sourcing › Independent verification · 26 May 2026 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #61 · Compounds › Tirzepatide · 17 May 2026 · 0 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
How this community escalates rather than diagnoses — does this still hold? Replied, post #2 · Safety › Adverse events · 9 May 2026 · 5 likes Picking up the opening post: that is the part I would want checked first. Reporting to regulatory agencies: if you have had a serious event, reporting it to the…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #30 · Clinical › Bloodwork · 8 May 2026 · 3 likes On post #26 — agreed on the reasoning, with one qualification. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone…
-
Request declined, with reasoning — what changed since Replied, post #34 · Meta › Feature requests · 28 Apr 2026 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Managing an unplanned gap in supply Replied, post #106 · Access › Shortages · 21 Apr 2026 · 0 likes I read post #104 twice before replying, because I had assumed the opposite. Supply interruptions: official shortage notices are published by regulatory agencies. That…
-
Choosing which test to pay for, given a fixed budget Replied, post #70 · Sourcing › Independent verification · 15 Apr 2026 · 4 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #35 · Compounds › Repair & healing peptides · 10 Apr 2026 · 1 like I read post #33 twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #57 · Practice › Administration · 6 Apr 2026 · 2 likes This follows post #54 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Grapefruit: why this class is not the class that cares Replied, post #84 · Practice › Interactions · 26 Mar 2026 · 28 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Personal import allowances, compared — a second dataset Replied, post #78 · Access › International · 2 Mar 2026 · 2 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #21 · Research Methods › N-of-1 designs · 28 Feb 2026 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Trifluoroacetate content and its consequences Replied, post #107 · Analytics › Impurities & related substances · 8 Feb 2026 · 13 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #46 · Practice › Interactions · 4 Feb 2026 · 13 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
[2026 update] What a good consultation looks like from the other side Replied, post #14 · Clinical › Prescriber conversations · 1 Feb 2026 · 0 likes Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and any questions written out. Written questions get better…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #71 · Pharmacology › Pharmacokinetics · 30 Jan 2026 · 0 likes post #70 is right about the mechanism and I think understates the practical bit. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
-
Heterogeneity as information rather than as a nuisance Replied, post #76 · Evidence › Meta-analyses · 25 Jan 2026 · 26 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #52 · Analytics › Method validation · 3 Jan 2026 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #20 · Regional › UK & Ireland · 29 Dec 2025 · 0 likes Worth separating two things that post #16 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Prescription requirements and telehealth models Replied, post #88 · Sourcing › Regulatory · 24 Dec 2025 · 25 likes post #87 is right about the mechanism and I think understates the practical bit. Approval versus licensing: a compound can be approved for a specific indication in one…
-
Tracking that stops updating and then resumes — the long version Replied, post #50 · Sourcing › Logistics · 12 Dec 2025 · 0 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Early satiety becoming a problem rather than a benefit Replied, post #13 · Practice › Side effects · 4 Dec 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Robustness: the parameters worth deliberately varying Replied, post #16 · Analytics › Method validation · 23 Nov 2025 · 31 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #98 · Compounds › Tirzepatide · 18 Nov 2025 · 22 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
What pooling buys you and what it destroys Replied, post #63 · Evidence › Meta-analyses · 10 Nov 2025 · 17 likes On post #59 — agreed on the reasoning, with one qualification. Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small…
-
Second pass at: Programming during a large energy deficit Replied, post #29 · Nutrition & Training › Resistance training · 5 Oct 2025 · 5 likes post #28 is right about the mechanism and I think understates the practical bit. Frequency: three sessions per week of full-body training is easier to maintain than…
-
Why catalogue breadth is not evidence of anything — what changed since Replied, post #54 · Compounds › Other compounds · 25 Sep 2025 · 12 likes This follows post #51 rather than contradicting it. Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #21 · Practice › Interactions · 23 Sep 2025 · 0 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #33 · Practice › Side effects · 2 Sep 2025 · 0 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
When a preprint is the best available evidence and we say so Replied, post #109 · Evidence › Preprints · 28 Aug 2025 · 31 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
When a preprint is the best available evidence and we say so Replied, post #68 · Evidence › Preprints · 18 Aug 2025 · 1 like Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #21 · Evidence › Journal club · 15 Aug 2025 · 28 likes Picking up post #18: that is the part I would want checked first. Session format: read the paper before posting. The discussion is much better when everyone has. Start…
-
A field-by-field walk through a certificate of analysis Replied, post #144 · Analytics › COA interpretation · 18 Jul 2025 · 9 likes This follows post #141 rather than contradicting it. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #43 · Data & Tools › Calculators · 5 Jul 2025 · 0 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #59 · Evidence › Journal club · 27 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #50 · Compounds › Repair & healing peptides · 25 Jun 2025 · 10 likes This follows post #47 rather than contradicting it. Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under…
-
Repeatability versus intermediate precision Replied, post #5 · Analytics › Method validation · 17 Jun 2025 · 5 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #40 · Compounds › Oral incretins · 31 May 2025 · 10 likes This follows post #37 rather than contradicting it. Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #98 · Compounds › Tirzepatide · 31 May 2025 · 8 likes On post #94 — agreed on the reasoning, with one qualification. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect…
-
Travel coolers and how long they really hold — the long version Replied, post #2 · marked as the solution · Devices › Cold chain · 18 May 2025 · 11 likes Shipping container and cold packs: reputable suppliers use insulated containers with cold packs designed to arrive cool. Checking on arrival that cold packs are still…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #40 · Evidence › Journal club · 16 May 2025 · 8 likes Picking up post #37: that is the part I would want checked first. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg…
-
Follow-up: Documentation that appears only after payment Replied, post #57 · Sourcing › Red flags · 8 May 2025 · 0 likes Worth separating two things that post #53 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #8 · Wellbeing › Mental health · 4 May 2025 · 0 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #103 · Compounds › Semaglutide · 4 May 2025 · 29 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Started this topic · Compounds › Secretagogues & GH axis · 24 Apr 2025 · 0 likes On the subject in the title: IGF-1 as a surrogate endpoint and its limitations — the long version Working notes rather than a conclusion. I have seen STEP 2 ( Lancet ,…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #46 · Compounds › Secretagogues & GH axis · 20 Apr 2025 · 7 likes Worth separating two things that post #42 runs together. Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #13 · Data & Tools › Calculators · 12 Apr 2025 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #123 · Access › International · 25 Mar 2025 · 3 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #111 · Analytics › COA interpretation · 22 Mar 2025 · 20 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Maintainer handover: how it works Replied, post #60 · Meta › Wiki maintenance · 17 Mar 2025 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #9 · Clinical › Bloodwork · 16 Mar 2025 · 25 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Validating a method you did not develop — does this still hold? Replied, post #106 · Analytics › Method validation · 12 Mar 2025 · 15 likes On post #102 — agreed on the reasoning, with one qualification. Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to…
-
Follow-up: What other technical communities get right that we do not Replied, post #36 · Lounge › Off topic · 10 Mar 2025 · 12 likes Coming back to post #34, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Consistent declarations and why they matter more than clever ones Replied, post #77 · Sourcing › Logistics · 23 Feb 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 24 Jan 2025 · 24 likes This follows post #52 rather than contradicting it. Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #20 · Sourcing › Vendor reports · 14 Jan 2025 · 1 like Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Identical chromatograms across two different lots Replied, post #74 · Sourcing › Red flags · 10 Jan 2025 · 17 likes Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact repeatedly in short time windows raises suspicion about stability and…
-
When to suspect the method rather than the sample Replied, post #61 · Analytics › Method validation · 5 Jan 2025 · 24 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
The topic list is dense — is that deliberate? Replied, post #68 · Meta › Site feedback · 17 Dec 2024 · 0 likes On post #64 — agreed on the reasoning, with one qualification. Display issues: broken layouts, images not loading, text overlapping — report with the browser and device…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #153 · Analytics › COA interpretation · 16 Dec 2024 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #54 · Evidence › Journal club · 8 Dec 2024 · 10 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Why "any advice?" is the least effective ending for a post Replied, post #108 · Start Here › How to Ask · 5 Dec 2024 · 0 likes Worth separating two things that post #104 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #18 · Meta › Wiki maintenance · 26 Oct 2024 · 4 likes Picking up post #15: that is the part I would want checked first. Outdated external links: if a maintained page links to external sources and those links are broken or…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #106 · Clinical › Bloodwork · 13 Oct 2024 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Guidelines revision: what changed and why Replied, post #42 · Meta › Announcements · 26 Jul 2024 · 9 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #12 · Compounds › Retatrutide · 16 Jul 2024 · 6 likes Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is ongoing, and the heart-rate signal in phase 2 is not negligible.…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #8 · Evidence › Journal club · 7 Jul 2024 · 1 like Coming back to post #6, because the follow-up matters more than the original answer. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…